Caplin Point Laboratories Limited (CAPLIPOINT.NS)
INR 2396.95
(0.02%)
INR 2396.95
(0.02%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 9.2 Billion INR | 0.0% |
| 2022 | 8.03 Billion INR | 14.37% |
| 2021 | 7.02 Billion INR | 22.58% |
| 2020 | 5.73 Billion INR | 28.3% |
| 2019 | 4.46 Billion INR | 24.74% |
| 2018 | 3.58 Billion INR | 19.28% |
| 2017 | 3 Billion INR | 44.04% |
| 2016 | 2.08 Billion INR | 130.65% |
| 2015 | 903.64 Million INR | -22.2% |
| 2014 | 1.16 Billion INR | 73.85% |
| 2013 | 668.1 Million INR | 57.64% |
| 2012 | 423.81 Million INR | 41.98% |
| 2011 | 298.49 Million INR | 92.53% |
| 2010 | 155.03 Million INR | 24.98% |
| 2009 | 124.04 Million INR | 24.87% |
| 2008 | 99.33 Million INR | -5.77% |
| 2007 | 105.42 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.17 Billion INR | 2.21% |
| 2023 Q2 | 2.45 Billion INR | 13.49% |
| 2023 Q3 | 2.45 Billion INR | -0.23% |
| 2023 Q4 | 2.12 Billion INR | -13.33% |
| 2023 Q1 | 2.16 Billion INR | 1.9% |
| 2023 FY | 8.03 Billion INR | 0.0% |
| 2022 Q2 | 1.93 Billion INR | 2.36% |
| 2022 Q4 | 2.12 Billion INR | 2.17% |
| 2022 FY | 8.03 Billion INR | 14.37% |
| 2022 Q1 | 1.89 Billion INR | 6.25% |
| 2022 Q3 | 2.08 Billion INR | 7.54% |
| 2021 Q1 | 1.64 Billion INR | 14.51% |
| 2021 Q2 | 1.77 Billion INR | 8.07% |
| 2021 Q3 | 1.82 Billion INR | 2.59% |
| 2021 Q4 | 1.77 Billion INR | -2.4% |
| 2021 FY | 7.02 Billion INR | 22.58% |
| 2020 Q1 | 1.31 Billion INR | 30.66% |
| 2020 Q2 | 1.47 Billion INR | 12.55% |
| 2020 Q4 | 1.43 Billion INR | -4.56% |
| 2020 Q3 | 1.5 Billion INR | 1.85% |
| 2020 FY | 5.73 Billion INR | 28.3% |
| 2019 Q4 | 1 Billion INR | -17.03% |
| 2019 Q1 | 1.07 Billion INR | 8.08% |
| 2019 Q2 | 1.17 Billion INR | 9.69% |
| 2019 FY | 4.46 Billion INR | 24.74% |
| 2019 Q3 | 1.21 Billion INR | 2.82% |
| 2018 Q1 | 823.67 Million INR | 1.41% |
| 2018 Q3 | 908.09 Million INR | 6.09% |
| 2018 Q4 | 993.45 Million INR | 9.4% |
| 2018 FY | 3.58 Billion INR | 19.28% |
| 2018 Q2 | 855.93 Million INR | 3.92% |
| 2017 Q3 | 762.3 Million INR | 2.73% |
| 2017 Q1 | 700.03 Million INR | 3.87% |
| 2017 FY | 3 Billion INR | 44.04% |
| 2017 Q4 | 812.24 Million INR | 6.55% |
| 2017 Q2 | 742.03 Million INR | 6.0% |
| 2016 Q1 | 405.64 Million INR | -1.28% |
| 2016 FY | 2.08 Billion INR | 130.65% |
| 2016 Q4 | 673.95 Million INR | 10.63% |
| 2016 Q3 | 609.18 Million INR | 27640.19% |
| 2016 Q2 | -2.21 Million INR | -100.55% |
| 2015 Q1 | 343.56 Million INR | 13.33% |
| 2015 Q2 | 362.18 Million INR | 5.42% |
| 2015 Q4 | 410.92 Million INR | 2.13% |
| 2015 FY | 903.64 Million INR | -22.2% |
| 2015 Q3 | 402.37 Million INR | 11.1% |
| 2014 Q2 | 243.93 Million INR | -4.31% |
| 2014 Q3 | 270.73 Million INR | 10.98% |
| 2014 FY | 1.16 Billion INR | 73.85% |
| 2014 Q1 | 254.91 Million INR | 80.53% |
| 2014 Q4 | 303.16 Million INR | 11.98% |
| 2013 Q2 | 160.17 Million INR | 18.46% |
| 2013 Q4 | 141.2 Million INR | -12.39% |
| 2013 FY | 668.1 Million INR | 57.64% |
| 2013 Q1 | 135.21 Million INR | 40.82% |
| 2013 Q3 | 161.17 Million INR | 0.62% |
| 2012 Q2 | 82.32 Million INR | -22.36% |
| 2012 Q1 | 106.03 Million INR | 69.55% |
| 2012 Q4 | 96.01 Million INR | -12.92% |
| 2012 FY | 423.81 Million INR | 41.98% |
| 2012 Q3 | 110.25 Million INR | 33.93% |
| 2011 Q2 | 51.8 Million INR | 0.0% |
| 2011 FY | 298.49 Million INR | 92.53% |
| 2011 Q4 | 62.54 Million INR | -19.94% |
| 2011 Q3 | 78.11 Million INR | 50.81% |
| 2010 FY | 155.03 Million INR | 24.98% |
| 2009 FY | 124.04 Million INR | 24.87% |
| 2008 FY | 99.33 Million INR | -5.77% |
| 2007 FY | 105.42 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sigachi Industries Limited | 2 Billion INR | -359.8% |
| Ind-Swift Limited | 2.17 Billion INR | -323.768% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -525.524% |
| Sakar Healthcare Limited | 699.58 Million INR | -1215.994% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 91.596% |
| Innova Captab Limited | 3.46 Billion INR | -165.743% |
| Divi's Laboratories Limited | 32.44 Billion INR | 71.62% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -47.95% |
| Morepen Laboratories Limited | 6.16 Billion INR | -49.425% |
| Mankind Pharma Limited | 42.19 Billion INR | 78.182% |
| Sequent Scientific Limited | 2.97 Billion INR | -209.075% |
| Wanbury Limited | 1.73 Billion INR | -431.97% |
| Laurus Labs Limited | 15.44 Billion INR | 40.406% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -90.876% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 25.951% |
| Alembic Limited | 1 Billion INR | -820.552% |
| Hikal Limited | 5.95 Billion INR | -54.523% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 65.623% |
| Neuland Laboratories Limited | 8.24 Billion INR | -11.623% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 39.665% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 86.723% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -95.09% |
| Themis Medicare Limited | 2.42 Billion INR | -280.433% |
| RPG Life Sciences Limited | 2.48 Billion INR | -270.781% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 92.647% |
| Lupin Limited | 125.09 Billion INR | 92.64% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -339.653% |
| Wockhardt Limited | 7.72 Billion INR | -19.255% |
| Vaishali Pharma Limited | 90.32 Million INR | -10092.863% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -57.879% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -1310.763% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 53.131% |
| FDC Limited | 6.58 Billion INR | -39.784% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 94.373% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -1383.778% |
| Eris Lifesciences Limited | 10.42 Billion INR | 11.703% |
| Venus Remedies Limited | 2.18 Billion INR | -321.816% |
| ZIM Laboratories Limited | 1.26 Billion INR | -626.172% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -149.132% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -1639.912% |
| Shilpa Medicare Limited | 3.56 Billion INR | -158.472% |
| Albert David Limited | 1.4 Billion INR | -553.83% |
| Ajanta Pharma Limited | 21.06 Billion INR | 56.293% |
| Hester Biosciences Limited | 1.27 Billion INR | -622.844% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -123.281% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 655.982% |
| Gufic Biosciences Limited | 4.07 Billion INR | -125.997% |
| Windlas Biotech Limited | 1.33 Billion INR | -587.668% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -59.243% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -8045.255% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -1231.972% |
| Granules India Limited | 16.79 Billion INR | 45.197% |
| Aarti Drugs Limited | 8.31 Billion INR | -10.706% |
| Bal Pharma Limited | 770.19 Million INR | -1095.347% |
| Alkem Laboratories Limited | 52.29 Billion INR | 82.396% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 96.438% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -387.925% |
| Medicamen Biotech Limited | 495.49 Million INR | -1758.041% |
| Unichem Laboratories Limited | 4.86 Billion INR | -89.242% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -1936.147% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -73287.804% |
| Valiant Laboratories Limited | 138.02 Million INR | -6569.975% |
| Orchid Pharma Limited | 2.32 Billion INR | -296.78% |
| Medico Remedies Limited | 262.14 Million INR | -3412.001% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -122.744% |
| Ipca Laboratories Limited | 48.58 Billion INR | 81.05% |
| Brooks Laboratories Limited | 65.62 Million INR | -13930.021% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -1545.478% |
| Piramal Enterprises Limited | 8.04 Billion INR | -14.462% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 80.31% |
| NATCO Pharma Limited | 25.73 Billion INR | 64.227% |
| Suven Life Sciences Limited | -200.79 Million INR | 4684.979% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 8565.981% |
| Strides Pharma Science Limited | 14.38 Billion INR | 36.013% |
| Indoco Remedies Limited | 8.04 Billion INR | -14.466% |
| Alpa Laboratories Limited | 188.89 Million INR | -4773.872% |
| Lasa Supergenerics Limited | 121.02 Million INR | -7506.792% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -2254.206% |